Interleukin 13-Induced Inflammation Increases DPP4 Abundance but Does Not Enhance Middle East Respiratory Syndrome

Kun Li1, Jennifer A Bartlett1, Christine L Wohlford-Lenane1

  • 1Department of Pediatrics, Pappajohn Biomedical Institute, Carver College of Medicine, University of Iowa, Iowa City, IA.

PubMed
Abstract

Insights

Individuals with chronic lung conditions like asthma may not be more susceptible to Middle East respiratory syndrome coronavirus (MERS-CoV) due to increased DPP4 receptor levels. Other factors likely influence MERS-CoV infection severity.

Area of Science:

  • Virology
  • Immunology
  • Pulmonology

Background:

  • Chronic pulmonary conditions, including asthma and COPD, elevate MERS-CoV morbidity and mortality risks.
  • Increased expression of the MERS-CoV receptor, dipeptidyl peptidase 4 (DPP4), was hypothesized as a cause for heightened susceptibility.

Purpose of the Study:

  • To investigate the impact of Th2 inflammation, mimicking chronic airway disease, on DPP4 expression and MERS-CoV susceptibility.
  • To determine if elevated DPP4 levels in airway epithelia influence MERS-CoV entry and replication.

Main Methods:

  • Primary human airway epithelia were treated with the Th2 cytokine IL-13 to model chronic airway disease.
  • DPP4 protein levels, MERS-CoV entry, and replication were assessed following IL-13 exposure.
  • Goblet cell metaplasia and transcriptional changes were analyzed.

Main Results:

  • Short-term (3-day) IL-13 exposure increased DPP4 protein abundance.
  • Long-term (21-day) IL-13 treatment elevated DPP4 levels and induced goblet cell metaplasia.
  • Despite increased DPP4, MERS-CoV entry and replication were not significantly affected by IL-13 treatment.

Conclusions:

  • Elevated DPP4 levels alone do not appear to be the primary driver of increased MERS severity in Th2-inflamed airways.
  • IL-13 significantly alters gene expression in airway epithelia, impacting innate immunity and antiviral responses.
  • Complex interactions between DPP4 abundance and other factors likely dictate MERS-CoV infection outcomes.

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...